SI1194140T1 - Pharmaceutical composition containing fenofibrate and preparation method - Google Patents

Pharmaceutical composition containing fenofibrate and preparation method

Info

Publication number: SI1194140T1
Authority: SI; Slovenia
Prior art keywords: pharmaceutical composition; surfactant; preparation; composition containing; cellulose derivative
Prior art date: 1999-07-09

Application number

SI200030633T

Other languages

English (en)

Slovenian (sl)

Inventor

Bruno Criere

Pascal Suplie

Philippe Chenevier

Original Assignee

Ethypharm

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-09

Filing date

2000-07-07

Publication date

2005-06-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1194140(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-07-07 Application filed by Ethypharm filed Critical Ethypharm

2005-06-30 Publication of SI1194140T1 publication Critical patent/SI1194140T1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Biophysics (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

SI200030633T 1999-07-09 2000-07-07 Pharmaceutical composition containing fenofibrate and preparation method SI1194140T1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9908923A FR2795961B1 (fr)	1999-07-09	1999-07-09	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
EP00949677A EP1194140B1 (de)	1999-07-09	2000-07-07	Fenofibrat enthaltende pharmazeutische zusammensetzung und verfahren zu ihrer herstellung
PCT/FR2000/001971 WO2001003693A1 (fr)	1999-07-09	2000-07-07	Composition pharmaceutique contenant du fenofibrate et procede de preparation

Publications (1)

Publication Number	Publication Date
SI1194140T1 true SI1194140T1 (en)	2005-06-30

Family

ID=9547923

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI200030894T SI1574214T1 (sl)	1999-07-09	2000-07-07	Farmacevtska zmes, ki vsebuje fenofibrat, in postopek njene izdelave
SI200030633T SI1194140T1 (en)	1999-07-09	2000-07-07	Pharmaceutical composition containing fenofibrate and preparation method

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SI200030894T SI1574214T1 (sl)	1999-07-09	2000-07-07	Farmacevtska zmes, ki vsebuje fenofibrat, in postopek njene izdelave

Country Status (37)

Country	Link
US (4)	US7101574B1 (de)
EP (3)	EP1523983B1 (de)
JP (2)	JP4841092B2 (de)
KR (3)	KR20020025188A (de)
CN (2)	CN1204885C (de)
AT (3)	ATE341320T1 (de)
AU (1)	AU782282B2 (de)
BG (1)	BG65504B1 (de)
BR (1)	BR0012335A (de)
CA (1)	CA2377909C (de)
CY (1)	CY1106206T1 (de)
CZ (1)	CZ300094B6 (de)
DE (3)	DE60031184T2 (de)
DK (3)	DK1194140T3 (de)
EA (1)	EA004294B1 (de)
EE (1)	EE04995B1 (de)
ES (3)	ES2309438T3 (de)
FR (1)	FR2795961B1 (de)
GE (1)	GEP20043287B (de)
HK (3)	HK1044894B (de)
HR (1)	HRP20020111B1 (de)
HU (1)	HU229044B1 (de)
IL (2)	IL147499A0 (de)
IS (1)	IS2157B (de)
ME (1)	ME01361B (de)
MX (1)	MXPA02000324A (de)
NO (1)	NO333301B1 (de)
NZ (1)	NZ516416A (de)
PL (1)	PL212082B1 (de)
PT (3)	PT1523983E (de)
RS (1)	RS50035B (de)
SI (2)	SI1574214T1 (de)
SK (1)	SK287484B6 (de)
TR (1)	TR200200008T2 (de)
UA (1)	UA72925C2 (de)
WO (1)	WO2001003693A1 (de)
ZA (1)	ZA200200169B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7863331B2 (en)	1999-07-09	2011-01-04	Ethypharm	Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr)	1999-07-09	2004-05-28	Ethypharm Lab Prod Ethiques	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US20080241070A1 (en) *	2000-09-21	2008-10-02	Elan Pharma International Ltd.	Fenofibrate dosage forms
FR2819720B1 (fr) *	2001-01-22	2004-03-12	Fournier Lab Sa	Nouveaux comprimes de fenofibrate
GB0119480D0 (en)	2001-08-09	2001-10-03	Jagotec Ag	Novel compositions
AU2003270778B2 (en) *	2002-09-20	2009-10-08	Alpharma Pharmaceuticals, Llc	Sequestering subunit and related compositions and methods
AU2003263480A1 (en) *	2002-09-24	2004-04-19	Ranbaxy Laboratories Limited	Oral pharmaceutical compositions of fenofibrate having high bioavailability
CN100367947C (zh) *	2002-12-04	2008-02-13	徐州恩华赛德药业有限责任公司	具有抗高血脂症的含非诺贝特的药物组合物
RU2356549C2 (ru) *	2002-12-17	2009-05-27	Эббетт ГмбХ унд Ко.КГ	Композиция, включающая фенофибриновую кислоту, ее физиологически приемлемую соль или производное
US20080051411A1 (en) *	2002-12-17	2008-02-28	Cink Russell D	Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
EP1832285A1 (de) *	2002-12-17	2007-09-12	Abbott GmbH & Co. KG	Formulierung mit Fenofibrinsäure oder einem physiologisch verträglichen Salz davon
EP1643975A2 (de) *	2003-07-02	2006-04-12	Abbott Laboratories	Verfahren zur herstellung von formulierungen von lipid-regelnden arzneimitteln
US7264813B2 (en) *	2003-09-24	2007-09-04	Nikken Sohonsha Corporation	Therapeutic uses of Dunaliella powder
US8062664B2 (en)	2003-11-12	2011-11-22	Abbott Laboratories	Process for preparing formulations of lipid-regulating drugs
US8026281B2 (en) *	2004-10-14	2011-09-27	Lupin Atlantis Holdings, S.A.	Treating metabolic syndrome with fenofibrate
AU2006218193A1 (en) *	2005-02-25	2006-08-31	F. Hoffmann-La Roche Ag	Tablets with improved drug substance dispersibility
EP1861084A1 (de) *	2005-03-30	2007-12-05	Teva Pharmaceutical Industries Ltd.	Verbesserte fenofibratformulierungen mit menthol und/oder peg/poloxamer
US20080152714A1 (en) *	2005-04-08	2008-06-26	Yi Gao	Pharmaceutical Formulations
WO2007134397A1 (en) *	2006-05-23	2007-11-29	Intelemetrix Ltd	Data accessing system and method
HUE032156T2 (en)	2006-06-19	2017-09-28	Alpharma Pharmaceuticals Llc	Pharmaceutical preparations
KR100767349B1 (ko) *	2006-08-01	2007-10-17	삼천당제약주식회사	페노피브레이트를 함유하는 경구용 약제 조성물 및 그의제조방법
EP1923053A1 (de) *	2006-09-27	2008-05-21	Novartis AG	Pharmazeutische Zusammensetzung umfassend Nilotinib oder dessen Salz
JP2010506833A (ja) *	2006-10-11	2010-03-04	アルファーマ，インコーポレイテッド	医薬組成物
JP4993274B2 (ja) *	2006-12-05	2012-08-08	日医工株式会社	フェノフィブラート含有製剤組成物の製造方法
US8623418B2 (en)	2007-12-17	2014-01-07	Alpharma Pharmaceuticals Llc	Pharmaceutical composition
AU2008338442A1 (en) *	2007-12-17	2009-06-25	Alpharma Pharmaceuticals, Llc	Pharmaceutical composition
FR2940118B1 (fr) *	2008-12-24	2013-08-09	Ethypharm Sa	Formulation pharmaceutique de fenofibrate nanonise
WO2010092925A1 (ja) *	2009-02-12	2010-08-19	あすか製薬株式会社	固体分散体とその医薬組成物、並びにそれらの製造方法
CN101502497B (zh) *	2009-03-06	2010-11-10	安徽省药物研究所	非诺贝特药物组合物
US20100291201A1 (en) *	2009-05-14	2010-11-18	Cerovene, Inc.	Coated pharmaceutical capsule dosage form
KR101202994B1 (ko) *	2010-04-12	2012-11-21	한미사이언스 주식회사	페노피브린산 및 알칼리화제를 포함하는 경구용 약학 조성물
US20140255480A1 (en) *	2011-09-07	2014-09-11	Ethypharm	Pharmaceutical formulation of nanonized fenofibrate
KR101334585B1 (ko) *	2012-05-29	2013-12-05	주식회사 브이터치	프로젝터를 통해 표시되는 정보를 이용하여 가상터치를 수행하는 원격 조작 장치 및 방법
US8722083B2 (en)	2012-06-25	2014-05-13	Mylan, Inc.	Fenofibrate formulation
WO2014091318A1 (en)	2012-12-11	2014-06-19	Lupin Atlantis Holdings, S.A.	Reduced dose pharmaceutical compositions of fenofibrate
WO2015084696A1 (en) *	2013-12-04	2015-06-11	Dow Global Technologies Llc	Process for preparing a mixture of a cellulose derivative and a liquid diluent
CN104352466A (zh) *	2014-11-17	2015-02-18	辰欣药业股份有限公司	一种非诺贝特组合物及其制剂
CN107961224B (zh) *	2017-12-06	2021-05-04	齐鲁制药(海南)有限公司	一种阿昔替尼片及其制备方法
KR102407512B1 (ko)	2019-10-30	2022-06-13	주식회사 대웅테라퓨틱스	피브레이트계 화합물을 포함하는 근육 질환 예방 및 치료용 조성물
CN112121022A (zh) *	2020-09-25	2020-12-25	迪沙药业集团有限公司	一种非诺贝特片组合物及其制备方法
KR102489384B1 (ko) *	2020-09-29	2023-01-18	애드파마 주식회사	생체이용율이 개선된 페노피브레이트 입자를 포함하는 약제학적 조성물
CN112121023A (zh) *	2020-09-30	2020-12-25	迪沙药业集团有限公司	一种非诺贝特片组合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4058552A (en)	1969-01-31	1977-11-15	Orchimed Sa	Esters of p-carbonylphenoxy-isobutyric acids
CH543472A (fr)	1969-01-31	1973-10-31	Orchimed Sa	Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
GB1579818A (en)	1977-06-07	1980-11-26	Yamanouchi Pharma Co Ltd	Nifedipine-containing solid preparation composition
ATE5852T1 (de)	1978-11-20	1984-02-15	American Home Products Corporation	Therapeutische zusammensetzungen mit gesteigerter bioverfuegbarkeit und verfahren zu deren herstellung.
US4344934A (en)	1978-11-20	1982-08-17	American Home Products Corporation	Therapeutic compositions with enhanced bioavailability
FR2494112B1 (de) *	1980-11-19	1986-01-10	Laruelle Claude
GB8414220D0 (en)	1984-06-04	1984-07-11	Sterwin Ag	Medicaments in unit dose form
GB8414221D0 (en)	1984-06-04	1984-07-11	Sterwin Ag	Unit dosage form
FR2602423B1 (fr) *	1986-08-08	1989-05-05	Ethypharm Sa	Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4752470A (en)	1986-11-24	1988-06-21	Mehta Atul M	Controlled release indomethacin
US4895725A (en) *	1987-08-24	1990-01-23	Clinical Technologies Associates, Inc.	Microencapsulation of fish oil
FR2627696B1 (fr)	1988-02-26	1991-09-13	Fournier Innovation Synergie	Nouvelle forme galenique du fenofibrate
ES2056470T3 (es)	1990-07-02	1994-10-01	Boehringer Mannheim Gmbh	Proceso para la obtencion de dosis unitarias de liberacion retardada, prensadas en molde, y las dosis unitarias correspondientes.
JP3125221B2 (ja) *	1990-09-01	2001-01-15	大正製薬株式会社	ソファルコン含有固形製剤
JP3037393B2 (ja) *	1990-10-22	2000-04-24	大正薬品工業株式会社	経口投与用固形薬剤の製造方法
US5145684A (en)	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
US5223268A (en) *	1991-05-16	1993-06-29	Sterling Drug, Inc.	Low solubility drug-coated bead compositions
DK0519144T3 (da) *	1991-06-21	1998-03-23	Ilsan Ilac Ve Hammaddeleri San	Ny galenisk proces for omeprazol indeholdende pellets
SE9402422D0 (sv)	1994-07-08	1994-07-08	Astra Ab	New beads for controlled release and a pharmaceutical preparation containing the same
FR2722984B1 (fr)	1994-07-26	1996-10-18	Effik Lab	Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5545628A (en) *	1995-01-10	1996-08-13	Galephar P.R. Inc.	Pharmaceutical composition containing fenofibrate
US5558879A (en) *	1995-04-28	1996-09-24	Andrx Pharmaceuticals, Inc.	Controlled release formulation for water soluble drugs in which a passageway is formed in situ
DE19608750A1 (de)	1996-03-06	1997-09-11	Durachemie Gmbh & Co Kg	Verfahren zur Herstellung von Fenofibrat-Präparaten
EP0914100A1 (de) *	1996-06-28	1999-05-12	Schering Corporation	Orale zubereitung die als antifungizide mittel triazole enthalten
FR2758461A1 (fr)	1997-01-17	1998-07-24	Pharma Pass	Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr)	1997-01-17	1999-05-07	Pharma Pass	Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
WO1999032612A1 (en) *	1997-12-20	1999-07-01	Genencor International, Inc.	Fluidized bed matrix granule
JP2000086509A (ja) *	1998-09-14	2000-03-28	Taisho Yakuhin Kogyo Kk	ソファルコン含有製剤の製造方法
FR2783421B1 (fr) *	1998-09-17	2000-11-24	Cll Pharma	Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
US6368620B2 (en) *	1999-06-11	2002-04-09	Abbott Laboratories	Formulations comprising lipid-regulating agents
FR2795961B1 (fr) *	1999-07-09	2004-05-28	Ethypharm Lab Prod Ethiques	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) *	1999-07-09	2011-01-04	Ethypharm	Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US6667064B2 (en)	2000-08-30	2003-12-23	Pilot Therapeutics, Inc.	Composition and method for treatment of hypertriglyceridemia
AU6294501A (en) *	2000-09-20	2002-04-02	Rtp Pharma Inc	Spray drying process and compositions of fenofibrate
US8026281B2 (en)	2004-10-14	2011-09-27	Lupin Atlantis Holdings, S.A.	Treating metabolic syndrome with fenofibrate

1999
- 1999-07-09 FR FR9908923A patent/FR2795961B1/fr not_active Expired - Lifetime
2000
- 2000-07-07 DE DE60031184T patent/DE60031184T2/de not_active Expired - Lifetime
- 2000-07-07 PL PL352307A patent/PL212082B1/pl unknown
- 2000-07-07 EA EA200200147A patent/EA004294B1/ru not_active IP Right Cessation
- 2000-07-07 EE EEP200200011A patent/EE04995B1/xx unknown
- 2000-07-07 AU AU62960/00A patent/AU782282B2/en not_active Expired
- 2000-07-07 WO PCT/FR2000/001971 patent/WO2001003693A1/fr not_active Application Discontinuation
- 2000-07-07 DE DE60019120T patent/DE60019120T2/de not_active Expired - Lifetime
- 2000-07-07 PT PT04027226T patent/PT1523983E/pt unknown
- 2000-07-07 ES ES04027226T patent/ES2309438T3/es not_active Expired - Lifetime
- 2000-07-07 ES ES00949677T patent/ES2235919T3/es not_active Expired - Lifetime
- 2000-07-07 NZ NZ516416A patent/NZ516416A/en not_active IP Right Cessation
- 2000-07-07 EP EP04027226A patent/EP1523983B1/de not_active Expired - Lifetime
- 2000-07-07 ES ES05006751T patent/ES2271924T3/es not_active Expired - Lifetime
- 2000-07-07 IL IL14749900A patent/IL147499A0/xx active IP Right Grant
- 2000-07-07 AT AT05006751T patent/ATE341320T1/de active
- 2000-07-07 BR BR0012335-8A patent/BR0012335A/pt not_active Application Discontinuation
- 2000-07-07 TR TR2002/00008T patent/TR200200008T2/xx unknown
- 2000-07-07 AT AT04027226T patent/ATE399006T1/de active
- 2000-07-07 DK DK00949677T patent/DK1194140T3/da active
- 2000-07-07 CN CNB008101469A patent/CN1204885C/zh not_active Expired - Lifetime
- 2000-07-07 PT PT05006751T patent/PT1574214E/pt unknown
- 2000-07-07 DE DE60039313T patent/DE60039313D1/de not_active Expired - Lifetime
- 2000-07-07 CN CN2005100648532A patent/CN1682707B/zh not_active Expired - Lifetime
- 2000-07-07 KR KR1020027000329A patent/KR20020025188A/ko not_active Application Discontinuation
- 2000-07-07 GE GEAP20006316A patent/GEP20043287B/en unknown
- 2000-07-07 SK SK15-2002A patent/SK287484B6/sk not_active IP Right Cessation
- 2000-07-07 CZ CZ20020002A patent/CZ300094B6/cs not_active IP Right Cessation
- 2000-07-07 DK DK04027226T patent/DK1523983T3/da active
- 2000-07-07 JP JP2001508973A patent/JP4841092B2/ja not_active Expired - Lifetime
- 2000-07-07 HU HU0202338A patent/HU229044B1/hu not_active IP Right Cessation
- 2000-07-07 SI SI200030894T patent/SI1574214T1/sl unknown
- 2000-07-07 US US10/030,262 patent/US7101574B1/en not_active Expired - Lifetime
- 2000-07-07 UA UA2002021052A patent/UA72925C2/uk unknown
- 2000-07-07 CA CA2377909A patent/CA2377909C/fr not_active Expired - Lifetime
- 2000-07-07 MX MXPA02000324A patent/MXPA02000324A/es active IP Right Grant
- 2000-07-07 SI SI200030633T patent/SI1194140T1/xx unknown
- 2000-07-07 EP EP05006751A patent/EP1574214B1/de not_active Expired - Lifetime
- 2000-07-07 ME MEP-2001-932A patent/ME01361B/me unknown
- 2000-07-07 DK DK05006751T patent/DK1574214T3/da active
- 2000-07-07 RS YUP-932/01A patent/RS50035B/sr unknown
- 2000-07-07 PT PT00949677T patent/PT1194140E/pt unknown
- 2000-07-07 AT AT00949677T patent/ATE291912T1/de active
- 2000-07-07 EP EP00949677A patent/EP1194140B1/de not_active Expired - Lifetime
2002
- 2002-01-02 NO NO20020014A patent/NO333301B1/no not_active IP Right Cessation
- 2002-01-03 IS IS6218A patent/IS2157B/is unknown
- 2002-01-04 BG BG106280A patent/BG65504B1/bg unknown
- 2002-01-07 IL IL147499A patent/IL147499A/en unknown
- 2002-01-09 ZA ZA200200169A patent/ZA200200169B/en unknown
- 2002-02-05 HR HR20020111A patent/HRP20020111B1/xx not_active IP Right Cessation
- 2002-08-30 HK HK02106433.0A patent/HK1044894B/zh not_active IP Right Cessation
2005
- 2005-10-04 HK HK05108777A patent/HK1074588A1/xx not_active IP Right Cessation
2006
- 2006-03-09 HK HK06103039A patent/HK1080391A1/xx not_active IP Right Cessation
- 2006-05-29 KR KR1020060048212A patent/KR20060073549A/ko not_active Application Discontinuation
- 2006-08-25 US US11/509,806 patent/US8658212B2/en not_active Expired - Lifetime
- 2006-10-18 CY CY20061101495T patent/CY1106206T1/el unknown
2007
- 2007-02-02 KR KR1020070010902A patent/KR100766644B1/ko active IP Right Grant
2008
- 2008-06-11 US US12/155,937 patent/US20080248101A1/en not_active Abandoned
2010
- 2010-06-25 US US12/823,900 patent/US8563042B2/en not_active Expired - Fee Related
2011
- 2011-03-15 JP JP2011057117A patent/JP2011148813A/ja active Pending

Also Published As

Publication number	Publication date
HK1044894B (zh)	2005-06-24
IL147499A0 (en)	2002-08-14
ES2235919T3 (es)	2005-07-16
US8563042B2 (en)	2013-10-22
HK1074588A1 (en)	2005-11-18
TR200200008T2 (tr)	2002-06-21
US20080248101A1 (en)	2008-10-09
ATE341320T1 (de)	2006-10-15
YU93201A (sh)	2004-09-03
CZ300094B6 (cs)	2009-01-28
EP1574214B1 (de)	2006-10-04
US20110159082A1 (en)	2011-06-30
AU6296000A (en)	2001-01-30
US20070071812A1 (en)	2007-03-29
BG106280A (en)	2002-08-30
BG65504B1 (bg)	2008-10-31
ES2271924T3 (es)	2007-04-16
JP2003504331A (ja)	2003-02-04
PT1523983E (pt)	2008-09-19
BR0012335A (pt)	2002-03-19
DK1574214T3 (da)	2007-01-22
RS50035B (sr)	2008-11-28
NO20020014D0 (no)	2002-01-02
CN1204885C (zh)	2005-06-08
NO333301B1 (no)	2013-04-29
IS6218A (is)	2002-01-03
DE60019120D1 (de)	2005-05-04
HUP0202338A3 (en)	2003-03-28
IL147499A (en)	2007-03-08
EE04995B1 (et)	2008-04-15
CN1682707B (zh)	2010-05-05
CN1682707A (zh)	2005-10-19
UA72925C2 (uk)	2005-05-16
CN1360499A (zh)	2002-07-24
WO2001003693A1 (fr)	2001-01-18
EP1194140B1 (de)	2005-03-30
US8658212B2 (en)	2014-02-25
KR20070026716A (ko)	2007-03-08
HRP20020111A2 (en)	2003-04-30
EE200200011A (et)	2003-02-17
KR20020025188A (ko)	2002-04-03
US7101574B1 (en)	2006-09-05
DK1523983T3 (da)	2008-10-13
AU782282B2 (en)	2005-07-14
DE60039313D1 (de)	2008-08-07
ZA200200169B (en)	2002-07-31
DK1194140T3 (da)	2005-07-04
EA200200147A1 (ru)	2002-06-27
SI1574214T1 (sl)	2006-12-31
EA004294B1 (ru)	2004-02-26
CY1106206T1 (el)	2011-06-08
KR100766644B1 (ko)	2007-10-15
EP1523983A1 (de)	2005-04-20
CZ20022A3 (cs)	2002-05-15
PL352307A1 (en)	2003-08-11
MXPA02000324A (es)	2002-06-21
HK1044894A1 (en)	2002-11-08
HK1080391A1 (en)	2006-04-28
CA2377909A1 (fr)	2001-01-18
SK287484B6 (sk)	2010-11-08
JP2011148813A (ja)	2011-08-04
CA2377909C (fr)	2011-06-28
HRP20020111B1 (en)	2005-12-31
FR2795961B1 (fr)	2004-05-28
ATE399006T1 (de)	2008-07-15
SK152002A3 (en)	2002-07-02
FR2795961A1 (fr)	2001-01-12
NO20020014L (no)	2002-03-04
DE60031184D1 (de)	2006-11-16
PL212082B1 (pl)	2012-08-31
PT1574214E (pt)	2007-01-31
EP1523983B1 (de)	2008-06-25
NZ516416A (en)	2003-10-31
EP1194140A1 (de)	2002-04-10
HU229044B1 (hu)	2013-07-29
ES2309438T3 (es)	2008-12-16
HUP0202338A2 (en)	2002-10-28
GEP20043287B (en)	2004-07-26
DE60019120T2 (de)	2006-02-09
IS2157B (is)	2006-11-15
PT1194140E (pt)	2005-07-29
EP1574214A1 (de)	2005-09-14
ME01361B (me)	2008-11-28
ATE291912T1 (de)	2005-04-15
JP4841092B2 (ja)	2011-12-21
KR20060073549A (ko)	2006-06-28
DE60031184T2 (de)	2007-08-23

Publication	Publication Date	Title
HK1044894A1 (en)	2002-11-08	Pharmaceutical composition containing fenofibrate and preparation method.
HUT52030A (en)	1990-06-28	Fungicide, insecticide and miticide compositions containing propene-carboxylic acid derivatives as active components and process for producing the active components
HUP0103567A3 (en)	2003-01-28	2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists, process for their preparation and pharmaceutical compositions containing the same
CA2225286A1 (en)	1997-01-09	A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
BR0012250A (pt)	2002-03-26	Processo de fabricação de grânulos revestidos com gosto mascarado, e liberação imediata do princìpio ativo, grânulo revestido, comprimido multiparticulado de dissolução rápida e comprimido de hidrodispersibilidade rápida
EP0326357A3 (de)	1989-10-25	Avermectinderivate
HUT52070A (en)	1990-06-28	Herbicide compositions containing pyrimidinyl-benzoic acid derivatives as active components, and process for producing the active components
CA2244767A1 (en)	1997-07-31	Process for the production of powdered pulmonary surfactant preparations
WO2001095856A3 (en)	2002-06-27	Urea derivative useful as an anti-cancer agent and process for preparing same
WO2001029055A3 (fr)	2002-02-14	Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
EA199700093A1 (ru)	1998-02-26	ЛЕКАРСТВЕННЫЕ ФОРМЫ ДЛЯ ПЕРОРАЛЬНОГО ВВЕДЕНИЯ, СОДЕРЖАЩИЕ β-ЛАКТАМНЫЙ АНТИБИОТИК
HUT47794A (en)	1989-04-28	Insecticide, acaricide and nematocide compositions containing pyridazinone derivatives as active components and process for producing the active components
AU692030B2 (en)	1998-05-28	Hydantoin derivatives, process for producing the same and herbicides comprising the same as active ingredients
HUP0004386A3 (en)	2002-08-28	Methylenebisphosphonic acid derivatives, process for producing them and medicaments containing the same as active agent
AU1465995A (en)	1995-08-08	N-phenyltetrahydrophthalamic acid derivative, process for producing the same, and herbicide containing the same as active ingredient
HU9801086D0 (en)	1998-07-28	New benzofurane derivatives, pharmaceutical compositions containing them as active component and process for producing the active component
AU2178299A (en)	1999-08-16	8-azabicyclo(3.2.1)oct-2-ene derivatives as pesticides
HUP9801085A3 (en)	2000-09-28	Piperazinyl-alkyl-benzofurane derivatives, pharmaceutical compositions containing them as active ingredient and process for producing the active ingredient